Close Menu
  • Home
  • News
  • Lifestyle
  • Law
  • Business
  • Education

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Ohio GOP Seeking to Change Voter-Approved Adult-Use Cannabis Law

May 30, 2025

U.S. Court of Appeals Rejects Legal Challenge Claiming Cannabis Prohibition is Unconstitutional

May 29, 2025

Montana Gov. Signs Bill Reserving $12M of Cannabis Tax Revenues for ‘Habitat Legacy Account’

May 28, 2025
Facebook X (Twitter) Instagram
Sunday, June 1
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions
Facebook X (Twitter) Instagram LinkedIn VKontakte
Smoke Professional
  • Home
  • News

    More Than 1,000 Arrested in Sweep of U.K. Weed Grows

    July 8, 2023

    Scotland Calls On UK To End ‘Failed’ Drug War With Decriminalization And Harm Reduction Approach

    July 8, 2023

    Germany’s draft law for first phase of cannabis reform

    July 8, 2023

    High Times Cannabis Cup Illinois: People’s Choice Edition 2023 Kicks Off

    July 8, 2023

    Pennsylvania Committee Advances Expansion to State Medical Cannabis Program

    July 7, 2023
  • Lifestyle

    How Watching the News Can Trigger Anxiety and Panic Attacks

    October 28, 2024

    Record High Cannabis and Hallucinogen Use Among Adults

    October 27, 2024

    Weekend Sleep Catch-Up May Lower Heart Disease Risk by 20%

    October 27, 2024

    Energy Drinks Linked to Poor Sleep Quality and Insomnia

    October 26, 2024

    First Psychedelic Church for Magic Mushrooms

    October 26, 2024
  • Law

    Ohio GOP Seeking to Change Voter-Approved Adult-Use Cannabis Law

    May 30, 2025

    Federal Lawmakers Call for Medicaid Fraud Investigation Into Florida Anti-Cannabis Political Group

    May 26, 2025

    Minnesota Ends Criminal Penalties for Bong Water

    May 23, 2025

    Minnesota Bill to Set Up Adult-Use Cannabis Industry Moves to Governor

    May 22, 2025

    Pennsylvania House Passes Cannabis Legalization Bill

    May 8, 2025
  • Business

    U.S. Court of Appeals Rejects Legal Challenge Claiming Cannabis Prohibition is Unconstitutional

    May 29, 2025

    Montana Gov. Signs Bill Reserving $12M of Cannabis Tax Revenues for ‘Habitat Legacy Account’

    May 28, 2025

    Minnesota Tribe Signs Agreements to Open Adult-Use Dispensaries Off Tribal Land

    May 28, 2025

    Washington to Issue New Social Equity Cannabis Licenses This Summer

    May 27, 2025

    DEA Raid Confiscates Over 29,000 Cannabis Plants in New York

    May 26, 2025
  • Education

    CBD and the Aging Population—What Science Says Today

    March 12, 2025

    Wholesale Nootropic Skincare: Boost Your Product Line

    March 10, 2025

    Ideal for Your Business Needs

    March 8, 2025

    A Must-have For Every Smoke Shop

    March 3, 2025

    The Perfect Addition to Your Product Line

    March 1, 2025
Smoke Professional
You are at:Home»Education»Study Finds Lower Opioid Prescription Rates in Areas with Cannabis Dispensaries Nearby
Education

Study Finds Lower Opioid Prescription Rates in Areas with Cannabis Dispensaries Nearby

adminBy adminJune 17, 2024No Comments5 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

The results of a recent study found that closer proximity to cannabis dispensaries in a community leads to a lower rate of opioid prescription. The study entitled “Recreational cannabis dispensary access effects on prescription opioid use and mortality,” was made available online in June but will be published in Regional Science and Urban Economics in its September 2024 issue.

Steven J. Dundas of Oregon State University and Jason W. Beasley of Western Michigan University (a former student of Dundas’) used Oregon as an example to examine opioid prescriptions and mortality rates and how they changed based on the number of cannabis dispensaries nearby. The data they used stemmed from the Oregon Health Authority’s Public Health Division from January 2014-December 2017, which researchers explained “captures nearly two years of data pre- and post-RCL [recreational cannabis legalization] in Oregon.”

“This paper addresses the question of whether access to recreational cannabis is a relevant factor impacting demand for prescription opioids within a community,” researchers explained. “We combine neighborhood-scale opioid prescription data and recreational cannabis dispensary locations in the U.S. state of Oregon (OR) to investigate the impact of changes to cannabis access on opioid prescriptions.”

Dundas and Beasley reviewed Oregon-based communities that are within one mile of a licensed cannabis dispensary and found that prescription opioid rates were lower compared to areas without dispensaries close by. “Using distance bins to identify the non-linear effect of recreational dispensary access, our empirical results suggest mean prescription opioids per capita fell by 1.0–3.9% after recreational legalization in communities near cannabis dispensaries,” the study stated. “Our results show that the further individuals must travel to a recreational dispensary, the higher the rates of prescription opioids per capita.”

In contrast, communities that had a dispensary located within one to four miles had higher prescription opioid rates. As the radius distance increased to a range of a dispensary being located four to 10 miles away from a community, or 10 to miles away, the prescription rates continued to increase.

This evidence suggests that if there are close alternatives to cannabis products from dispensaries that can be used to opioid prescriptions, residents are more likely to consider switching to cannabis for treatment. However, they also noted that while opioid-related mortality rates have quadrupled between 2005-2022, these results don’t have much of an effect on opioid-related mortality. “Despite the reduction, we find no evidence that reducing barriers to cannabis access and subsequent declines in prescription opioids are associated with meaningful changes in opioid mortality,” the researchers wrote.

Other studies have previously examined the opioid mortality rates associated with exposure to medical and/or recreational cannabis. A study published on June 5 in JAMA Network Open examined the case of 175,734 patients and why they consumed cannabis within the past three months. “While most patients (76.1%) reported using cannabis to manage a health symptom, very few patients identified as medical cannabis users.” Those consumers still used cannabis for common conditions such as pain, stress, and as a sleep aid. “Less than half the patients who used cannabis reported using it for medical reasons, even though the majority of patients reported cannabis use to manage a health-related symptom,” that report stated.

Another study published at the start of the year in BJM Open found evidence that cannabis has potential in acting as a substitute for opioids, specifically when helping patients manage pain. A total of 22,028 patient’s profiles were reviewed across 84 randomized controlled trials, which showed that cannabis offered similar relief that opioids provided without any negative side effects. “Our findings suggest that both opioids and cannabis for medical use may provide benefits for a minority of chronic pain patients,” researchers wrote. “Furthermore, cannabis does not cause respiratory depression which can result from opioids consumption and lead to non-fatal or fatal overdose.”

In February, another study published in the Harm Reduction Journal developed a clinical framework to help patients use cannabis to treat chronic pain if they are opioid-dependent. “Based on a comprehensive review of the literature and epidemiological evidence to date, cannabinoids stand to be one of the most interesting, safe, and accessible tools available to attenuate the devastation resulting from the misuse and abuse of opioid narcotics,” researchers explained. 

Research published earlier in May in the journal Pain also shared that injecting terpenes is more effective than injecting morphine-based chemo medications, and there are far fewer adverse effects. “What we found is that terpenes are really good at relieving a specific type of chronic pain with side effects that are low and manageable,” said researcher John Streicher. The study used five terpenes (alpha-humulene, beta-caryophyllene, beta-pinene, geraniol, and linalool) and tested on mice with a focus on neuropathic pain (a common condition that is developed by chemotherapy medications). All of the terpenes showed signs of pain reduction, especially when combined. “We looked at other aspects of the terpenes, such as does this cause reward? Is this going to be addictive? Is it going to make you feel awful?” Streicher said. “What we found was yes, terpenes do relieve pain, and they also have a pretty good side effect profile.”

Source link

Areas cannabis Dispensaries Finds Nearby Opioid Prescription Rates study
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleNew Hampshire Lawmakers May be Nearing Adult-Use Cannabis Legalization Deal
Next Article The American Medical Association Voted To Approve Drug Decriminalization
admin
  • Website

Related Posts

Ohio GOP Seeking to Change Voter-Approved Adult-Use Cannabis Law

May 30, 2025

U.S. Court of Appeals Rejects Legal Challenge Claiming Cannabis Prohibition is Unconstitutional

May 29, 2025

Montana Gov. Signs Bill Reserving $12M of Cannabis Tax Revenues for ‘Habitat Legacy Account’

May 28, 2025

Comments are closed.

Our Picks

Ohio GOP Seeking to Change Voter-Approved Adult-Use Cannabis Law

May 30, 2025

U.S. Court of Appeals Rejects Legal Challenge Claiming Cannabis Prohibition is Unconstitutional

May 29, 2025

Montana Gov. Signs Bill Reserving $12M of Cannabis Tax Revenues for ‘Habitat Legacy Account’

May 28, 2025

Minnesota Tribe Signs Agreements to Open Adult-Use Dispensaries Off Tribal Land

May 28, 2025
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Law

Ohio GOP Seeking to Change Voter-Approved Adult-Use Cannabis Law

By adminMay 30, 20250

Republican lawmakers in Ohio are seeking to make changes to the 2023 cannabis legalization law approved…

U.S. Court of Appeals Rejects Legal Challenge Claiming Cannabis Prohibition is Unconstitutional

May 29, 2025

Montana Gov. Signs Bill Reserving $12M of Cannabis Tax Revenues for ‘Habitat Legacy Account’

May 28, 2025

Minnesota Tribe Signs Agreements to Open Adult-Use Dispensaries Off Tribal Land

May 28, 2025

Subscribe to Updates

Get the latest creative news from Smoke Unlimited about Weed & CBD vaping.

From Our Partners
About Us
About Us

Get all the current news stories, latest trends and legislation regarding cannabidiol, products, usages and its benefits. So don’t miss out any buzz and stay tuned! We offer a minute to minute updates regarding Marijuana industry.

Facebook X (Twitter) Instagram Pinterest
Our Picks

Ohio GOP Seeking to Change Voter-Approved Adult-Use Cannabis Law

May 30, 2025

U.S. Court of Appeals Rejects Legal Challenge Claiming Cannabis Prohibition is Unconstitutional

May 29, 2025

Montana Gov. Signs Bill Reserving $12M of Cannabis Tax Revenues for ‘Habitat Legacy Account’

May 28, 2025
Sponsors
Copyright © 2025. SmokeProfessional
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.